CD4 and rheumatoid arthritis: Genetic instruments indicate that GSDMB is the most consistently protective gasdermin across immune lineages and diseases: higher expression in naïve and effector CD4+/CD8+ T cells associates with lower risk of UC, CD, rheumatoid arthritis, and AS, while showing a lone, opposite signal of increased liability in PSC.